October 06, 2020 Hints of moderation emerge in biotech venture funding Venture cash raised by private drug developers dipped slightly after two record-breaking quarters, but the party is far from over.
October 07, 2019 Venture cash gets even more concentrated The latest venture capital numbers suggest that 2019 will see a healthy amount raised, but the falling number of rounds could be a worry.